Em. Sotomayor et al., ENHANCEMENT OF MACROPHAGE TUMORICIDAL ACTIVITY BY THE ALKALOID DERIVATIVE UKRAIN - INVITRO AND INVIVO STUDIES, Drugs under experimental and clinical research, 18, 1992, pp. 5-11
Ukrain is a semisynthetic drug with immunomodulatory properties, deriv
ed from Chelidonium majus L. alkaloids and thiophosphoric acid. The ef
fect of this compound on the growth of Balb/c syngenic mammary adenoca
rcinoma was assessed. Intravenous, but not subcutaneous or intraperito
neal, administration of this drug was found to be effective in delayin
g tumour growth in an actual therapeutic protocol initiated five days
after tumour implantation. No untoward side-effects were observed usin
g these in vivo treatment modalities. The role of macrophages in the o
bserved retardation of tumour development was investigated using perit
oneal exudate macrophages (PEM) in cytotoxicity assays. In previous st
udies, the authors have found that PEM of mammary tumour bearing mice
lose their capacity to kill a variety of tumour target cells including
the in vitro cultured homologous tumour cells (DA-3). Pretreatment of
PEM from normal mice with 2.5 muM Ukrain for 24 h followed by stimula
tion with either IFN-gamma or with LPS + IFN-gamma enhanced their cyto
toxic activity. Treatment of PEM from tumour bearing mice with 2.5 muM
Ukrain and LPS results in a reversal of their defective cytotoxic res
ponse against the DA-3 target cells. Furthermore, Ukrain alone, in the
absence of a secondary signal, induced the activation of tumouricidal
function of PEM from tumour bearing but not from normal mice. These d
ata indicate that Ukrain's in vivo effects against the development of
mammary tumours may be due, at least in part, to its ability to restor
e macrophage cytolytic function.